2012
DOI: 10.1128/mbio.00338-12
|View full text |Cite
|
Sign up to set email alerts
|

Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing

Abstract: Fecal microbiome transplantation by low-volume enema is an effective, safe, and inexpensive alternative to antibiotic therapy for patients with chronic relapsing Clostridium difficile infection (CDI). We explored the microbial diversity of pre- and posttransplant stool specimens from CDI patients (n = 6) using deep sequencing of the 16S rRNA gene. While interindividual variability in microbiota change occurs with fecal transplantation and vancomycin exposure, in this pilot study we note that clinical cure of C… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

15
125
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(141 citation statements)
references
References 47 publications
15
125
1
Order By: Relevance
“…In adults, prior to FMT for recurrent CDI, there is decreased bacterial diversity compared to healthy donors (39)(40)(41). After FMT, microbiota diversity increases in fecal samples and microbiome composition shifts towards the healthy donor (39).…”
Section: Fecal Transplant In Childrenmentioning
confidence: 99%
“…In adults, prior to FMT for recurrent CDI, there is decreased bacterial diversity compared to healthy donors (39)(40)(41). After FMT, microbiota diversity increases in fecal samples and microbiome composition shifts towards the healthy donor (39).…”
Section: Fecal Transplant In Childrenmentioning
confidence: 99%
“…Preliminary results have shown that one of the taxa found in high proportions in patients with CDI is Proteobacteria, while Bacteroidetes proportions are lower in infected patients [207]. In this context, one study has proposed the use of Bacteroidetes and Firmicutes as probiotics to treat CDI [208]. However, the few available data regarding alterations to the intestinal microbiota of patients with CDI has been obtained in different patient conditions (age, antibiotic treatment, hospitalisation), which explains the high amount of variability between the studies.…”
Section: High-throughput Sequencing Analysis and CDImentioning
confidence: 99%
“…Patients with CDI harbour an intestinal microbiota with a characteristic reduced diversity owing to antibiotic use (Chang et al, 2008;Shahinas et al, 2012). We hypothesized that patients with recurrent CDI also show a composition favourable for the overgrowth of C. difficile, lacking specific signature microbes that prevent them to return to a sustainable homeostatic status after infection, resulting in recurrences.…”
Section: Introductionmentioning
confidence: 99%